DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
LY-3009120
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Melanoma; Neoplasm Metastasis
Serine/threonine-protein kinase A-Raf inhibitor
LY-3009120
×
Maximum Phase:
1
First Approval:
None
UNII:
1GDT36RARO
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-8245
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
MK-8245
×
Maximum Phase:
1
First Approval:
None
UNII:
537E7QE8LX
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrFN6O4
Molecular Weight:
467.26
AlogP:
2.36
PSA:
119.4
HBD:
1.0
HBA:
#RotB:
6.0
Source:
MEPHEDRONE
1
Small molecule
Investigational
Unknown
Unknown
Amphetamine-Related Disorders
Unknown
MEPHEDRONE
×
Maximum Phase:
1
First Approval:
None
UNII:
8BA8T27317
Molecule Type:
Small molecule
Molecular Formula:
C11H15NO
Molecular Weight:
177.25
AlogP:
1.79
PSA:
29.1
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ETC-159
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
ETC-159
×
Maximum Phase:
1
First Approval:
None
UNII:
5L854240DQ
Molecule Type:
Small molecule
Molecular Formula:
C19H17N7O3
Molecular Weight:
391.39
AlogP:
0.53
PSA:
116.7
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SELITRECTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
SELITRECTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
0J45910S3X
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN6O
Molecular Weight:
380.43
AlogP:
2.67
PSA:
75.42
HBD:
1.0
HBA:
#RotB:
0.0
Source:
RX-518
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RX-518
×
Maximum Phase:
1
First Approval:
None
UNII:
708TLB8J3Y
Molecule Type:
Small molecule
Molecular Formula:
C29H28F2N6O2
Molecular Weight:
530.58
AlogP:
4.56
PSA:
93.62
HBD:
3.0
HBA:
#RotB:
8.0
Source:
CORDYCEPIN
1
Small molecule
Investigational
Unknown
Unknown
Leukemia
Unknown
CORDYCEPIN
×
Maximum Phase:
1
First Approval:
None
UNII:
GZ8VF4M2J8
Molecule Type:
Small molecule
Molecular Formula:
C10H13N5O3
Molecular Weight:
251.25
AlogP:
-0.95
PSA:
119.31
HBD:
3.0
HBA:
#RotB:
2.0
Source:
CFG-920
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CFG-920
×
Maximum Phase:
1
First Approval:
None
UNII:
UP0K5026VB
Molecule Type:
Small molecule
Molecular Formula:
C14H13ClN4O
Molecular Weight:
288.74
AlogP:
2.89
PSA:
49.33
HBD:
0.0
HBA:
#RotB:
2.0
Source:
BMS-908662
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-908662
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
ORDOPIDINE
1
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Dopamine D2 receptor modulator
ORDOPIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
0P43SIA7J6
Molecule Type:
Small molecule
Molecular Formula:
C14H20FNO2S
Molecular Weight:
285.38
AlogP:
2.43
PSA:
37.38
HBD:
0.0
HBA:
#RotB:
3.0
Source:
YTTRIUM Y-90
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Unknown
YTTRIUM Y-90
×
Maximum Phase:
1
First Approval:
None
UNII:
1K8M7UR6O1
Molecule Type:
Small molecule
Molecular Formula:
Y
Molecular Weight:
89.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CLENBUTEROL
1
Small molecule
Investigational
Unknown
Unknown
Amyotrophic Lateral Sclerosis; Glycogen Storage Disease Type II; Parkinson Disease; Lung Diseases, Obstructive
Beta-2 adrenergic receptor agonist
CLENBUTEROL
×
Maximum Phase:
1
First Approval:
None
UNII:
XTZ6AXU7KN
Molecule Type:
Small molecule
Molecular Formula:
C12H18Cl2N2O
Molecular Weight:
277.2
AlogP:
3.0
PSA:
58.28
HBD:
3.0
HBA:
#RotB:
3.0
Source:
FK453
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A1 receptor antagonist
FK453
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C23H25N3O2
Molecular Weight:
375.47
AlogP:
3.78
PSA:
57.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
SECLIDEMSTAT
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Sarcoma, Ewing
Unknown
SECLIDEMSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
TYH386V3WJ
Molecule Type:
Small molecule
Molecular Formula:
C20H23ClN4O4S
Molecular Weight:
450.95
AlogP:
2.14
PSA:
102.31
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CORT 108297
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Glucocorticoid receptor antagonist
CORT 108297
×
Maximum Phase:
1
First Approval:
None
UNII:
A17W0640NB
Molecule Type:
Small molecule
Molecular Formula:
C26H25F4N3O3S
Molecular Weight:
535.56
AlogP:
5.09
PSA:
64.43
HBD:
0.0
HBA:
#RotB:
6.0
Source:
PF-06260414
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-06260414
×
Maximum Phase:
1
First Approval:
None
UNII:
3I487UHH95
Molecule Type:
Small molecule
Molecular Formula:
C14H14N4O2S
Molecular Weight:
302.36
AlogP:
1.4
PSA:
86.09
HBD:
1.0
HBA:
#RotB:
1.0
Source:
AC-1204
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AC-1204
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BMS-962212
1
Small molecule
Investigational
Unknown
Unknown
Thrombosis
Unknown
BMS-962212
×
Maximum Phase:
1
First Approval:
None
UNII:
VWJ4VVZ3OU
Molecule Type:
Small molecule
Molecular Formula:
C32H28ClFN8O5
Molecular Weight:
659.08
AlogP:
3.21
PSA:
153.86
HBD:
2.0
HBA:
#RotB:
7.0
Source:
IRX4310
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Retinoic acid receptor antagonist
IRX4310
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UC-781
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
UC-781
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MIVEBRESIB
1
Small molecule
Investigational
Unknown
Unknown
Primary Myelofibrosis
Unknown
MIVEBRESIB
×
Maximum Phase:
1
First Approval:
None
UNII:
VR86R11J7J
Molecule Type:
Small molecule
Molecular Formula:
C22H19F2N3O4S
Molecular Weight:
459.47
AlogP:
4.37
PSA:
93.19
HBD:
2.0
HBA:
#RotB:
6.0
Source:
PIMASERTIB HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
PIMASERTIB HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
6GS1ULF5HV
Molecule Type:
Small molecule
Molecular Formula:
C15H16ClFIN3O3
Molecular Weight:
467.67
AlogP:
1.65
PSA:
94.48
HBD:
4.0
HBA:
#RotB:
6.0
Source:
MITOGLITAZONE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Diabetes Mellitus, Type 2
Unknown
MITOGLITAZONE
×
Maximum Phase:
2
First Approval:
None
UNII:
29I7RP18RG
Molecule Type:
Small molecule
Molecular Formula:
C19H18N2O4S
Molecular Weight:
370.43
AlogP:
2.8
PSA:
85.36
HBD:
1.0
HBA:
#RotB:
7.0
Source:
MITEMCINAL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MITEMCINAL
×
Maximum Phase:
2
First Approval:
None
UNII:
6X5NRJ664L
Molecule Type:
Small molecule
Molecular Formula:
C40H69NO12
Molecular Weight:
755.99
AlogP:
4.53
PSA:
151.68
HBD:
2.0
HBA:
#RotB:
9.0
Source:
EVATANEPAG
2
Small molecule
Investigational
Unknown
Unknown
Tibial Fractures
Prostanoid EP2 receptor agonist
EVATANEPAG
×
Maximum Phase:
2
First Approval:
None
UNII:
L266R6E31E
Molecule Type:
Small molecule
Molecular Formula:
C25H28N2O5S
Molecular Weight:
468.58
AlogP:
4.23
PSA:
96.8
HBD:
1.0
HBA:
#RotB:
9.0
Source:
BMS-275183
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Non-Small-Cell Lung
Tubulin stabiliser
BMS-275183
×
Maximum Phase:
2
First Approval:
None
UNII:
UQC681JJIV
Molecule Type:
Small molecule
Molecular Formula:
C43H59NO16
Molecular Weight:
845.94
AlogP:
3.72
PSA:
239.75
HBD:
4.0
HBA:
#RotB:
8.0
Source:
SUVECALTAMIDE
2
Small molecule
Investigational
Unknown
Unknown
Epilepsy; Essential Tremor; Schizophrenia
Voltage-gated T-type calcium channel modulator
SUVECALTAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
MIA4WMP8QN
Molecule Type:
Small molecule
Molecular Formula:
C20H23F3N2O2
Molecular Weight:
380.41
AlogP:
4.57
PSA:
51.22
HBD:
1.0
HBA:
#RotB:
7.0
Source:
L-EFLORNITHINE HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
L-EFLORNITHINE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
UO07O10TCJ
Molecule Type:
Small molecule
Molecular Formula:
C6H13ClF2N2O2
Molecular Weight:
218.63
AlogP:
-0.23
PSA:
89.34
HBD:
3.0
HBA:
#RotB:
5.0
Source:
VALATEGRAST
2
Small molecule
Investigational
Unknown
Unknown
Asthma
Unknown
VALATEGRAST
×
Maximum Phase:
2
First Approval:
None
UNII:
06DM4KX7JG
Molecule Type:
Small molecule
Molecular Formula:
C30H32Cl3N3O4
Molecular Weight:
604.96
AlogP:
6.43
PSA:
87.74
HBD:
2.0
HBA:
#RotB:
12.0
Source:
MAVELERTINIB
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Epidermal growth factor receptor erbB1 inhibitor
MAVELERTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
YXX2180047
Molecule Type:
Small molecule
Molecular Formula:
C18H22FN9O2
Molecular Weight:
415.43
AlogP:
0.68
PSA:
115.02
HBD:
2.0
HBA:
#RotB:
6.0
Source:
LY2940094
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder; Alcoholism; Depressive Disorder, Major
Nociceptin receptor antagonist
LY2940094
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SELODENOSON
2
Small molecule
Investigational
Unknown
Unknown
Atrial Fibrillation
Adenosine A1 receptor agonist
SELODENOSON
×
Maximum Phase:
2
First Approval:
None
UNII:
103G5E953K
Molecule Type:
Small molecule
Molecular Formula:
C17H24N6O4
Molecular Weight:
376.42
AlogP:
-0.06
PSA:
134.42
HBD:
4.0
HBA:
#RotB:
5.0
Source:
GSK-1521498
2
Small molecule
Investigational
Unknown
Unknown
Alcoholism; Obesity
Mu opioid receptor antagonist
GSK-1521498
×
Maximum Phase:
2
First Approval:
None
UNII:
W0UTB622GK
Molecule Type:
Small molecule
Molecular Formula:
C24H20F2N4
Molecular Weight:
402.45
AlogP:
4.67
PSA:
53.6
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ENMD-981693
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Pancreatic Neoplasms
Fibroblast growth factor receptor inhibitor
ENMD-981693
×
Maximum Phase:
2
First Approval:
None
UNII:
DNZ11VPY7Q
Molecule Type:
Small molecule
Molecular Formula:
C22H16N4O4
Molecular Weight:
400.39
AlogP:
3.15
PSA:
99.17
HBD:
1.0
HBA:
#RotB:
3.0
Source:
1
2
…
86
87
88
89
90
91
92
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA